Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEquity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Gsk (GLAXF) Revenue (2016 - 2025)

Historic Revenue for Gsk (GLAXF) over the last 17 years, with Q3 2025 value amounting to $11.5 billion.

  • Gsk's Revenue rose 1076.2% to $11.5 billion in Q3 2025 from the same period last year, while for Dec 2025 it was $31.7 billion, marking a year-over-year decrease of 3576.26%. This contributed to the annual value of $40.1 billion for FY2024, which is 632.11% up from last year.
  • Gsk's Revenue amounted to $11.5 billion in Q3 2025, which was up 1076.2% from $10.7 billion recorded in Q2 2025.
  • Over the past 5 years, Gsk's Revenue peaked at $19.6 billion during Q4 2024, and registered a low of $7.1 billion during Q1 2021.
  • Its 5-year average for Revenue is $10.8 billion, with a median of $9.5 billion in 2021.
  • Per our database at Business Quant, Gsk's Revenue tumbled by 3899.55% in 2021 and then soared by 7361.78% in 2022.
  • Quarter analysis of 5 years shows Gsk's Revenue stood at $9.5 billion in 2021, then soared by 73.62% to $16.6 billion in 2022, then grew by 5.89% to $17.5 billion in 2023, then increased by 11.59% to $19.6 billion in 2024, then tumbled by 41.08% to $11.5 billion in 2025.
  • Its Revenue stands at $11.5 billion for Q3 2025, versus $10.7 billion for Q2 2025 and $9.5 billion for Q1 2025.